wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38678038-7AE76450-03CB-40F0-9E62-2F8D76E3A649
Q38678038-7AE76450-03CB-40F0-9E62-2F8D76E3A649
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38678038-7AE76450-03CB-40F0-9E62-2F8D76E3A649
Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials.
P2860
Q38678038-7AE76450-03CB-40F0-9E62-2F8D76E3A649
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38678038-7AE76450-03CB-40F0-9E62-2F8D76E3A649
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eb7ca7ad0a71a908cf90383aea9301767548e90c
P2860
A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113.